GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Bodisen Biotech Inc (LSE:BODI) » Definitions » Enterprise Value

Bodisen Biotech (LSE:BODI) Enterprise Value : £1.29 Mil (As of May. 11, 2024)


View and export this data going back to . Start your Free Trial

What is Bodisen Biotech Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bodisen Biotech's Enterprise Value is £1.29 Mil. Bodisen Biotech's EBIT for the trailing twelve months (TTM) ended in Jun. 2013 was £-9.65 Mil. Therefore, Bodisen Biotech's EV-to-EBIT ratio for today is -0.13.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Bodisen Biotech's Enterprise Value is £1.29 Mil. Bodisen Biotech's EBITDA for the trailing twelve months (TTM) ended in Jun. 2013 was £-9.13 Mil. Therefore, Bodisen Biotech's EV-to-EBITDA ratio for today is -0.14.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Bodisen Biotech's Enterprise Value is £1.29 Mil. Bodisen Biotech's Revenue for the trailing twelve months (TTM) ended in Jun. 2013 was £3.88 Mil. Therefore, Bodisen Biotech's EV-to-Revenue ratio for today is 0.33.


Bodisen Biotech Enterprise Value Historical Data

The historical data trend for Bodisen Biotech's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech Enterprise Value Chart

Bodisen Biotech Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.84 -0.73 1.95 - 2.74

Bodisen Biotech Quarterly Data
Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Jun13
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.95 4.85 4.65 2.74 1.19

Competitive Comparison of Bodisen Biotech's Enterprise Value

For the Agricultural Inputs subindustry, Bodisen Biotech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bodisen Biotech's Enterprise Value Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Bodisen Biotech's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Bodisen Biotech's Enterprise Value falls into.



Bodisen Biotech Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Bodisen Biotech's Enterprise Value for the fiscal year that ended in Dec. 2012 is calculated as

Bodisen Biotech's Enterprise Value for the quarter that ended in Jun. 2013 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bodisen Biotech  (LSE:BODI) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Bodisen Biotech's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1.291/-9.651
=-0.13

Bodisen Biotech's current Enterprise Value is £1.29 Mil.
Bodisen Biotech's EBIT for the trailing twelve months (TTM) ended in Jun. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was £-9.65 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Bodisen Biotech's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1.291/-9.126
=-0.14

Bodisen Biotech's current Enterprise Value is £1.29 Mil.
Bodisen Biotech's EBITDA for the trailing twelve months (TTM) ended in Jun. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was £-9.13 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Bodisen Biotech's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1.291/3.877
=0.33

Bodisen Biotech's current Enterprise Value is £1.29 Mil.
Bodisen Biotech's Revenue for the trailing twelve months (TTM) ended in Jun. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was £3.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bodisen Biotech Enterprise Value Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Bodisen Biotech (LSE:BODI) Business Description

Traded in Other Exchanges
N/A
Address
Bodisen Biotech Inc develops, manufactures and sells organic fertilizers, liquid fertilizers, pesticides and insecticides in China.